AIG
OKUR

American International Group’s OnKure Therapeutics OKUR Stock Holding History

American International Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-633
Closed -$10.5K – 2838
2024
Q1 		$10.5K Sell
633
-12
-2% -$198 ﹤0.01% 2976
2023
Q4 		$10.3K Sell
645
-3
-0.5% -$187 ﹤0.01% 3009
2023
Q3 		$49.3K Buy
648
+182
+39% +$12.4K ﹤0.01% 2823
2023
Q2 		$30.6K Buy
+466
New +$37.5K ﹤0.01% 2973
2022
Q2 		– Sell
-432
Closed -$13K – 3295
2022
Q1 		$13K Sell
432
-30
-6% -$1.68K ﹤0.01% 3069
2021
Q4 		$39K Buy
462
+117
+34% +$8.59K ﹤0.01% 3015
2021
Q3 		$26K Sell
345
-8
-2% -$679 ﹤0.01% 3066
2021
Q2 		$33 Buy
+353
New +$39.4K ﹤0.01% 3045

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

American International Group's OKUR Position: Q2 2024 in Review

American International Group sold out of OnKure Therapeutics (OKUR) in Q2 2024, closing a stake of 633 shares — an estimated $10.5K sold.

American International Group first reported a position in OKUR in Q2 2021 and held it in 8 quarters. The position peaked at $49.3K in Q3 2023. 66 funds tracked by Wall St. Rank hold OKUR as of Q2 2024.

  • American International Group reported no remaining OnKure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 633 OnKure Therapeutics shares in Q2 2024, an estimated $10.5K.
  • American International Group first reported a position in OnKure Therapeutics in Q2 2021 and held it in 8 quarters.
  • American International Group's OnKure Therapeutics position peaked at $49.3K in Q3 2023.
  • 66 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.